BSE Live
Jan 01, 16:01Prev. Close
73.25
Open Price
72.11
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 01, 15:41Prev. Close
73.32
Open Price
71.50
Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5.20 | 6.63 | 5.09 | 4.46 | 1.10 | |
| Net CashFlow From Operating Activities | 14.38 | 13.31 | 16.34 | 12.86 | 11.29 | |
| Net Cash Used In Investing Activities | -6.07 | -7.30 | -4.02 | -2.22 | -2.77 | |
| Net Cash Used From Financing Activities | -6.80 | -7.52 | -10.62 | -9.58 | -8.17 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.51 | -1.51 | 1.70 | 1.06 | 0.35 | |
| Cash And Cash Equivalents Begin of Year | 3.02 | 4.53 | 3.03 | 1.97 | 1.61 | |
| Cash And Cash Equivalents End Of Year | 4.54 | 3.02 | 4.73 | 3.03 | 1.97 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y